Align 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19) (characterized)
to candidate PP_1770 PP_1770 3-phosphoshikimate 1-carboxyvinyltransferase
Query= BRENDA::Q83E11 (438 letters) >FitnessBrowser__Putida:PP_1770 Length = 746 Score = 466 bits (1198), Expect = e-135 Identities = 245/430 (56%), Positives = 306/430 (71%), Gaps = 6/430 (1%) Query: 3 YQTIPSQGLSGEICVPGDKSISHRAVLLAAIAEGQTQVDGFLMGADNLAMVSALQQMGAS 62 +Q P L+G I VPGDKSISHR+++L ++AEG T+V+GFL G D LA + A + MG Sbjct: 314 FQAQPGGRLNGRIRVPGDKSISHRSIMLGSLAEGTTEVEGFLEGEDALATLQAFRDMGV- 372 Query: 63 IQVIEDENI--LVVEGVGMTGLQAPPEALDCGNSGTAIRLLSGLLAGQPFNTVLTGDSSL 120 VIE N + + GVG+ GL+ PP L GNSGT++RLLSGLLAGQPF+ +TGD+SL Sbjct: 373 --VIEGPNHGRVTIHGVGLHGLKPPPGPLYVGNSGTSMRLLSGLLAGQPFDVTMTGDASL 430 Query: 121 QRRPMKRIIDPLTLMGAKIDS-TGNVPPLKIYGNPRLTGIHYQLPMASAQVKSCLLLAGL 179 +RPM R+ +PL MGA +++ PPL I G +L G+ Y LPMASAQVKSCLLLAGL Sbjct: 431 SKRPMNRVANPLREMGAVVETGPDGRPPLTIRGGHKLKGLTYTLPMASAQVKSCLLLAGL 490 Query: 180 YARGKTCITEPAPSRDHTERLLKHFHYTLQKDKQSICVSGGGKLKANDISIPGDISSAAF 239 YA GKT +TEPAP+RDHTER+L+ F Y++ + GGKL A I +P DISSAAF Sbjct: 491 YAEGKTTVTEPAPTRDHTERMLRGFGYSVDSHGPVASLQSGGKLTATRIEVPADISSAAF 550 Query: 240 FIVAATITPGSAIRLCRVGVNPTRLGVINLLKMMGADIEVTHYTEKNEEPTADITVRHAR 299 F+VAA+I GS + L VG+NPTR GVI++L++MG DI + + E EP AD+ VR A+ Sbjct: 551 FLVAASIAEGSELVLEHVGINPTRTGVIDILRLMGGDITLENQREVGGEPVADLRVRGAK 610 Query: 300 LKGIDIPPDQVPLTIDEFPVLLIAAAVAQGKTVLRDAAELRVKETDRIAAMVDGLQKLGI 359 LKGIDIP VPL IDEFPVL +AAA A+G+TVLR A ELRVKE+DRI M DGL LGI Sbjct: 611 LKGIDIPEALVPLAIDEFPVLFVAAACAEGRTVLRGAEELRVKESDRIQVMADGLTTLGI 670 Query: 360 AAESLPDGVIIQGGTLEGGEVNSYDDHRIAMAFAVAGTLAKGPVRIRNCDNVKTSFPNFV 419 E PDG+II GG + GGEV+ + DHRIAMAF+VA A P+RI +C NV TSFPNF+ Sbjct: 671 KCEPTPDGIIIDGGQMGGGEVHGHGDHRIAMAFSVASLRASAPIRIHDCANVATSFPNFL 730 Query: 420 ELANEVGMNV 429 L EVG+ V Sbjct: 731 ALCAEVGIRV 740 Lambda K H 0.318 0.137 0.392 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 935 Number of extensions: 40 Number of successful extensions: 4 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 438 Length of database: 746 Length adjustment: 36 Effective length of query: 402 Effective length of database: 710 Effective search space: 285420 Effective search space used: 285420 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.7 bits) S2: 53 (25.0 bits)
Align candidate PP_1770 PP_1770 (3-phosphoshikimate 1-carboxyvinyltransferase)
to HMM TIGR01356 (aroA: 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19))
# hmmsearch :: search profile(s) against a sequence database # HMMER 3.3.1 (Jul 2020); http://hmmer.org/ # Copyright (C) 2020 Howard Hughes Medical Institute. # Freely distributed under the BSD open source license. # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - # query HMM file: ../tmp/path.aa/TIGR01356.hmm # target sequence database: /tmp/gapView.28146.genome.faa # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Query: TIGR01356 [M=415] Accession: TIGR01356 Description: aroA: 3-phosphoshikimate 1-carboxyvinyltransferase Scores for complete sequences (score includes all domains): --- full sequence --- --- best 1 domain --- -#dom- E-value score bias E-value score bias exp N Sequence Description ------- ------ ----- ------- ------ ----- ---- -- -------- ----------- 5.7e-130 419.8 0.0 6.9e-130 419.5 0.0 1.1 1 lcl|FitnessBrowser__Putida:PP_1770 PP_1770 3-phosphoshikimate 1-car Domain annotation for each sequence (and alignments): >> lcl|FitnessBrowser__Putida:PP_1770 PP_1770 3-phosphoshikimate 1-carboxyvinyltransferase # score bias c-Evalue i-Evalue hmmfrom hmm to alifrom ali to envfrom env to acc --- ------ ----- --------- --------- ------- ------- ------- ------- ------- ------- ---- 1 ! 419.5 0.0 6.9e-130 6.9e-130 1 413 [. 324 737 .. 324 739 .. 0.95 Alignments for each domain: == domain 1 score: 419.5 bits; conditional E-value: 6.9e-130 TIGR01356 1 geikipgsKSishRalllaaLaegetvvtnlLkseDtlatlealrklGakve.eekeelviegvgg..lkepeae 72 g+i++pg+KSishR+++l++Laeg+t+v+++L++eD latl+a+r++G+ +e ++++++i+gvg lk p lcl|FitnessBrowser__Putida:PP_1770 324 GRIRVPGDKSISHRSIMLGSLAEGTTEVEGFLEGEDALATLQAFRDMGVVIEgPNHGRVTIHGVGLhgLKPPPGP 398 79**************************************************66699*******988899999** PP TIGR01356 73 ldlgnsGttaRlltgvlalasgevvltgdeslkkRPierlveaLrelgaeieskeeegslPlaisgplkg.give 146 l++gnsGt++Rll+g+la ++++v++tgd sl+kRP++r+ ++Lre+ga +e +g++Pl+i+g+ k+ g ++ lcl|FitnessBrowser__Putida:PP_1770 399 LYVGNSGTSMRLLSGLLAGQPFDVTMTGDASLSKRPMNRVANPLREMGAVVETGP-DGRPPLTIRGGHKLkGLTY 472 ***************************************************9866.79*********8888**** PP TIGR01356 147 lsgsaSsQyksalllaaplalqavtleivgeklisrpyieitLkllksfgveveeederkivvkggqkykqkeve 221 ++aS+Q+ks+llla+ l a++ ++v+e+ +r+++e++L ++ v+ + +++ g+k + +++e lcl|FitnessBrowser__Putida:PP_1770 473 TLPMASAQVKSCLLLAG---LYAEGKTTVTEPAPTRDHTERMLRGFGYS---VDSHGP-VASLQSGGKLTATRIE 540 *****************...67789999999***********9887755...888876.77888888877778** PP TIGR01356 222 vegDaSsAafflaaaaitge.evtvenlgenstqgdkaiiivLeemGadveveeqr........dvevegasklk 287 v++D+SsAaffl+aa i+++ e+++e++g+n+t+++ +i++L+ mG+d+++e+qr d++v+ga klk lcl|FitnessBrowser__Putida:PP_1770 541 VPADISSAAFFLVAASIAEGsELVLEHVGINPTRTG--VIDILRLMGGDITLENQRevggepvaDLRVRGA-KLK 612 *******************99***************..788****************************75.7** PP TIGR01356 288 gvkv.didvdsliDelptlavlaafAegetriknieelRvkEsdRiaaiaeeLeklGveveeledgllieGkkke 361 g+++ ++ v+ +iDe+p+l v+aa+Aeg t+++++eelRvkEsdRi+++a+ L++lG+++e+++dg++i G+ + lcl|FitnessBrowser__Putida:PP_1770 613 GIDIpEALVPLAIDEFPVLFVAAACAEGRTVLRGAEELRVKESDRIQVMADGLTTLGIKCEPTPDGIIIDGG--Q 685 ****99******************************************************************..6 PP TIGR01356 362 lkgavvdtydDHRiamalavlglaaegeveiedaecvaksfPeFfevleqlg 413 + g++v++++DHRiama++v++l+a+++++i+d + va+sfP+F+ + +++g lcl|FitnessBrowser__Putida:PP_1770 686 MGGGEVHGHGDHRIAMAFSVASLRASAPIRIHDCANVATSFPNFLALCAEVG 737 *********************************************9999886 PP Internal pipeline statistics summary: ------------------------------------- Query model(s): 1 (415 nodes) Target sequences: 1 (746 residues searched) Passed MSV filter: 1 (1); expected 0.0 (0.02) Passed bias filter: 1 (1); expected 0.0 (0.02) Passed Vit filter: 1 (1); expected 0.0 (0.001) Passed Fwd filter: 1 (1); expected 0.0 (1e-05) Initial search space (Z): 1 [actual number of targets] Domain search space (domZ): 1 [number of targets reported over threshold] # CPU time: 0.02u 0.00s 00:00:00.02 Elapsed: 00:00:00.01 # Mc/sec: 16.63 // [ok]
This GapMind analysis is from Apr 09 2024. The underlying query database was built on Apr 09 2024.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory